BioCentury
ARTICLE | Clinical News

Chiron regulatory update

February 8, 1999 8:00 AM UTC

The European Union granted marketing approval for CHIR's Triacelluvax diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine for infants and toddlers (see BioCentury, Part I). CHIR plans to market the vaccine, which has been approved in Italy since 1994, in all 15 EU countries except Germany. ...